HEART METABOLICS LTD is a biotechnology startup founded in 2012 and based in Ireland. The company is focused on developing a pharmaceutical therapy for the treatment of hypertrophic cardiomyopathy. In April 2014, Heart Metabolics successfully raised a $20.00M Series A investment from a group of prominent investors including Seroba Life Sciences, VenBio Partners, Brandon Capital, EQT Life Sciences, and AshHill Biomedical.
HEART METABOLICS LTD
Founded 2012
Ireland
1 employees
Series A
Total: $24.00M
Biotechnology, Health Care +1
Ireland
1 employees
Series A
Total: $24.00M
Biotechnology, Health Care +1
General Information
Company Name
HEART METABOLICS LTD
Founded Year
2012
Location
Ireland
Ireland
Employees
1
Industries
Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with HEART METABOLICS LTD. To contact HEART METABOLICS LTD, visit heartmetabolics.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
Ireland Market
Biotechnology
About HEART METABOLICS LTD
Taxonomy: pharmaceutical therapy, HCM treatment, cardiomyopathy, perhexiline, clinical trials, FDA approval, orphan drug designation, heart disease, cardiovascular drugs, medical innovation, startup, biopharmaceutical, heart failure, clinical research
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $20.00M | 5 |
|
16 Apr 2014 |
| Series A | $4.00M | 1 |
AshHill Biomedical
|
04 Jan 2013 |
HEART METABOLICS LTD Alternatives & Competitors
View All Alternatives
HEART METABOLICS LTD vs
Advancing transformative therapies for cardiovascular disease
Post-IPO Equity
6 employees
Biotechnology, Health Care
HEART METABOLICS LTD vs
Targazyme Inc. is a San Diego-based, clinical-stage biopharmaceutical company developing novel enzym...
Series A
11 employees
Biopharma, Biotechnology
HEART METABOLICS LTD vs
Reprieve Cardiovascular
United States
Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to impr...
Series A
24 employees
Health Care, Health and Wellness
FAQ About HEART METABOLICS LTD
Heart Metabolics is pioneering a pharmaceutical therapy for the treatment of hypertrophic cardiomyopathy.
HEART METABOLICS LTD was founded in 2012.
HEART METABOLICS LTD is headquartered in Ireland.
HEART METABOLICS LTD operates in Biotechnology, Health Care and Health and Wellness. Its work centres on pharmaceutical therapy, HCM treatment, cardiomyopathy and perhexiline.
HEART METABOLICS LTD has approximately 1 employees.
HEART METABOLICS LTD has completed 2 funding rounds, raising a total of $24.00M. The latest funding stage is Series A.
Top alternatives and competitors to HEART METABOLICS LTD include Renovacor, Targazyme, Reprieve Cardiovascular, Impulse Dynamics, Brainstorm Cell Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HEART METABOLICS LTD and Renovacor are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for HEART METABOLICS LTD, https://bouncewatch.com/company/heart-metabolics-ltd, updated 20 December 2024. When citing, please name BounceWatch and link this page.
